API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. 137215-12-4
2. Odiparcil [inn]
3. Fik1414zi8
4. Gsk 424323
5. 2h-1-benzopyran-2-one, 4-methyl-7-[(5-thio-beta-d-xylopyranosyl)oxy]-
6. 4-methyl-7-(((2r,3r,4s,5s)-3,4,5-trihydroxytetrahydro-2h-thiopyran-2-yl)oxy)-2h-chromen-2-one
7. Odiparcil [who-dd]
8. Dsstox_cid_31428
9. Dsstox_rid_97314
10. Unii-fik1414zi8
11. Dsstox_gsid_57639
12. Schembl4515803
13. Chembl2107763
14. Dtxsid4057639
15. Tox21_113853
16. Zinc31597280
17. 4-methyl-7-[(2r,3r,4s,5s)-3,4,5-trihydroxythian-2-yl]oxychromen-2-one
18. Db06609
19. Gsk-424323
20. Ncgc00253734-01
21. Bo167288
22. Sb 424323
23. Cas-137215-12-4
24. E98880
25. Q27278001
26. 4-methyl-7-(5-thio-beta-d-xylopyranosyloxy)-2h-chromen-2-one
27. 4-methyl-2-oxo-2h-1-benzopyran-7-yl 5-thio-beta-d-xylopyranoside
28. 2h-1-benzopyran-2-one, 4-methyl-7-[(5-thio-b-d-xylopyranosyl)oxy]-
29. 4-methyl-7-(5-thio-.beta.-d-xylopyranosyloxy)-2h-chromen-2-one
30. 7-((2r,3r,4s,5s)-tetrahydro-3,4,5-trihydroxy-2h-thiopyran-2-yloxy)-4-methyl-2h-chromen-2-one
Molecular Weight | 324.4 g/mol |
---|---|
Molecular Formula | C15H16O6S |
XLogP3 | 0.1 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 2 |
Exact Mass | 324.06675940 g/mol |
Monoisotopic Mass | 324.06675940 g/mol |
Topological Polar Surface Area | 122 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 467 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in atrial fibrillation, cardiovascular disorders, thrombosis, and venous thromboembolism.